Louis C Chiara, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 120 S Main St, Ste D, Milford, MI 48381 Phone: 248-684-1282 Fax: 248-684-2485 |
News Archive
BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.
The University HealthSystem Consortium (UHC) today announced that it has awarded a 3-year agreement to RGIS, based in Auburn Hills, Mich, for inventory counting services. The agreement, which has 2 automatic 1-year renewal periods, became effective on September 1, 2009.
Thirty-five people have died in the custody of U.S. Immigration and Customs Enforcement (ICE) since April 2018, with a seven-fold increase in deaths even as the average daily population decreased by nearly a third between 2019 and 2020, a new USC study shows.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment in elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
› Verified 3 days ago